WHO joins Europe, Merck in recommending against ivermectin for COVID-19
ZURICH - The World Health Organization (WHO) on Wednesday recommended against using generic anti-parasite drug ivermectin in patients with COVID-19 except for clinical trials, because of a lack of data demonstrating its benefits.The recommendation follows the European Medicines Agency's warning last week against the drug. The U.S. Food and Drug Administration (FDA) has also recommended it not be used for COVID-19. Officials in the Bolivian city of Trinidad launched a campaign in May last year to give out free doses of ivermectin to combat the coronavirus, although the South American country's health ministry noted the lack of evidence for it as a treatment.
More Related News